Vaginal Atrophy (Atrophic Vaginitis) - Pipeline Report, H2 2016: Therapeutic Review of 5 Companies & 6 Drug Profiles - Research and Markets

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Vaginal Atrophy (Atrophic Vaginitis) - Pipeline Review, H2 2016" report to their offering.

Pharmaceutical and Healthcare latest pipeline guide Vaginal Atrophy (Atrophic Vaginitis) - Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for Vaginal Atrophy (Atrophic Vaginitis) (Women's Health), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Vaginal Atrophy (Atrophic Vaginitis) (Women's Health) pipeline guide also reviews of key players involved in therapeutic development for Vaginal Atrophy (Atrophic Vaginitis) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II and Preclinical stages are 1, 2, 2 and 1 respectively.Vaginal Atrophy (Atrophic Vaginitis).

Vaginal Atrophy (Atrophic Vaginitis) (Women's Health) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Key Topics Covered:

1. Introduction
2. Vaginal Atrophy (Atrophic Vaginitis) Overview
3. Therapeutics Development
4. Pipeline Products for Vaginal Atrophy (Atrophic Vaginitis) - Overview
5. Vaginal Atrophy (Atrophic Vaginitis) - Therapeutics under Development by Companies
6. Vaginal Atrophy (Atrophic Vaginitis) - Pipeline Products Glance
7. Late Stage Products
8. Clinical Stage Products
9. Early Stage Products
10. Vaginal Atrophy (Atrophic Vaginitis) - Products under Development by Companies
11. Vaginal Atrophy (Atrophic Vaginitis) - Companies Involved in Therapeutics Development

• Allergan Plc
• EndoCeutics, Inc.
• Foamix Pharmaceuticals Ltd.
• Ligand Pharmaceuticals, Inc.
• Mithra Pharmaceuticals S.A.
• PEPTONIC medical AB

Drug Profiles

• estradiol hemihydrate
• lasofoxifene tartrate
• oxytocin
• prasterone
• WC-3011

For more information about this report visit http://www.researchandmarkets.com/research/6zrnx6/vaginal_atrophy